Search Now

Recommendations

Thursday, March 29, 2007

Market Watch & Insider Trades


Insider Trades:
Asian Paints Limited: Shri Ashwin Choksi, Chairman has purchased from open market 3500 equity shares of Asian Paints Limited on 26th march, 2007.

Tube Investments of India Ltd: Murugappa Group (Promoters) has purchased from open market 1250000 equity shares of Tube Investments of India Ltd on 15th March, 2007

Market Volumes:
The turnover on NSE was up by 19% to Rs83.63bn. The BSE Technology index was the major loser and lost 2.91%. BSE Auto index (down 2.63%), BSE Bank index (down 2.27%), BSE Consumer Durable index (down 2.23%) and BSE Capital Good index (down 1.62%) were among the other major losers.

Volume Toppers:
IFCI, SAIL, Gujarat Ambuja, Idea, R Com, Balrampur Chini, Satyam Computer, HLL, Bajaj Hindusthan, TTML, India Cement, Indiabulls, Infosys, Tata Motors, Tata Steel, Gujarat NRE and JP Hydro.

Lower Circuit:
GMR Industries, Harrison Malyalam, Kesoram Industries, Nahar Exports, Nesco Ltd, McLeod Russel, Ganesh Housing, Garware Offshore, HOV Services, KEI Industries, Atlanta and Vakran Software.

Delivery Delight:
Apollo Hospitals, ACC, Aurobindo Pharma, BHEL, Dr Reddys Laboratories, Jet Airways, Balrampur Chini Mills, Dwarikesh Sugar, Gujarat NRE Coke, Matrix Laboratories, Ranbaxy, ONGC, Tata Power, Tulip, Sakthi Sugars, Sesa Goa, Strides Arcolab, Uttam Sugar and Wockhardt.

Brokers Recommendations:
Sun Pharma – Accumulate from Edelweiss

Hotel Leela – Outperform from Macquire Research

Long Term investment:
Dr Reddy’s Laboratories

Major News Headlines:

FM sees growth staying 9% or above

Satyam signs Multi year deal with Applied Materials

Wockhardt gets USFDA nod for anti-inflammatory injection

Sun TV to consider stock split on 5th April

Polaris to pay Rs1.25 per mid-year dividend

Sterlite Optical gets order from PGCIL

Jagran Prakashan partners Yahoo India for Hindi website

Glenmark confirms ANDA filing with a Paragraph IV Certification for Zetia Tablets

ABG Shipyard secures $13.5mn Tug Order

Strides Arcolab gets ANDA approval from USFDA for Efavirenz tablets